CI&T (NYSE:CINT - Get Free Report) had its target price cut by investment analysts at TD Cowen from $6.00 to $5.00 in a research note issued on Wednesday,Benzinga reports. The brokerage currently has a "buy" rating on the stock. TD Cowen's price target would indicate a potential upside of 43.06% from the company's previous close.
Other analysts also recently issued reports about the stock. JPMorgan Chase & Co. reduced their price target on shares of CI&T from $6.00 to $5.00 and set an "overweight" rating for the company in a report on Wednesday. UBS Group dropped their price objective on shares of CI&T from $7.20 to $6.20 and set a "buy" rating on the stock in a report on Wednesday. Zacks Research lowered shares of CI&T from a "hold" rating to a "strong sell" rating in a research report on Tuesday, July 28th. Weiss Ratings cut shares of CI&T from a "hold (c-)" rating to a "sell (d+)" rating in a research note on Monday, June 29th. Finally, Wedbush downgraded CI&T from an "outperform" rating to a "neutral" rating and decreased their target price for the stock from $7.00 to $4.00 in a research report on Tuesday, July 21st. Seven investment analysts have rated the stock with a Buy rating, two have issued a Hold rating and two have given a Sell rating to the stock. According to MarketBeat, the stock presently has a consensus rating of "Hold" and an average price target of $6.08.
Get Our Latest Analysis on CINT
CI&T Stock Performance
NYSE CINT traded down $0.14 during trading on Wednesday, hitting $3.50. The company's stock had a trading volume of 116,798 shares, compared to its average volume of 143,188. The company has a quick ratio of 1.37, a current ratio of 1.37 and a debt-to-equity ratio of 0.18. The firm has a 50 day moving average price of $3.53 and a 200 day moving average price of $4.24. The firm has a market cap of $470.35 million, a P/E ratio of 11.27 and a beta of 0.81. CI&T has a 52 week low of $3.03 and a 52 week high of $5.88.
CI&T (NYSE:CINT - Get Free Report) last posted its quarterly earnings data on Tuesday, August 11th. The company reported $0.07 earnings per share for the quarter, missing the consensus estimate of $0.09 by ($0.02). The business had revenue of $142.82 million during the quarter, compared to the consensus estimate of $140.05 million. CI&T had a net margin of 7.90% and a return on equity of 13.19%. Equities research analysts forecast that CI&T will post 0.32 earnings per share for the current fiscal year.
Institutional Investors Weigh In On CI&T
Institutional investors have recently bought and sold shares of the business. GMT Capital Corp acquired a new stake in CI&T during the fourth quarter valued at approximately $1,786,000. Royce & Associates LP lifted its position in shares of CI&T by 69.7% during the 4th quarter. Royce & Associates LP now owns 888,221 shares of the company's stock worth $3,615,000 after buying an additional 364,696 shares during the period. BW Gestao de Investimentos Ltda. boosted its stake in CI&T by 9.2% in the 2nd quarter. BW Gestao de Investimentos Ltda. now owns 2,882,650 shares of the company's stock valued at $17,209,000 after buying an additional 242,811 shares in the last quarter. Marshall Wace LLP boosted its stake in CI&T by 90.4% in the 2nd quarter. Marshall Wace LLP now owns 380,818 shares of the company's stock valued at $2,273,000 after buying an additional 180,800 shares in the last quarter. Finally, XTX Topco Ltd bought a new stake in CI&T in the fourth quarter valued at $287,000. Institutional investors and hedge funds own 92.45% of the company's stock.
CI&T News Roundup
Here are the key news stories impacting CI&T this week:
- Positive Sentiment: CI&T reported 21.9% organic revenue growth in the second quarter, supported by momentum across geographies, industries and its client base. Revenue totaled approximately $142.8 million, exceeding the $140.1 million consensus estimate. CI&T Reports 21.9% Organic Revenue Growth in 2Q26
- Positive Sentiment: UBS lowered its price target from $7.20 to $6.20 but maintained a Buy rating. The revised target still implies substantial potential upside from the recent share price, signaling that UBS views the selloff as excessive relative to CI&T’s growth prospects. UBS price target update
- Neutral Sentiment: Full-year revenue guidance of $565.5 million to $577.8 million brackets the $570.0 million analyst consensus, suggesting management’s outlook is broadly in line with expectations. The available update did not provide a specific third-quarter or full-year EPS figure. CI&T earnings report
- Negative Sentiment: Second-quarter adjusted earnings were $0.07 per share, below the $0.09-$0.10 consensus estimate and unchanged from the year-ago period. The earnings miss indicates that strong sales growth has not yet translated into equivalent bottom-line expansion. CI&T Q2 Earnings Miss Estimates
- Negative Sentiment: The UBS price-target reduction may pressure sentiment despite the retained Buy rating, particularly because CINT trades well below its 50-day and 200-day moving averages and remains close to its 12-month low.
About CI&T
(
Get Free Report)
CI&T Inc NYSE: CINT is a global digital solutions and technology services provider specializing in end-to-end digital transformation. The company partners with clients across industries such as financial services, retail, healthcare and technology to deliver tailored software products, agile development practices and customer-centric design. Its core offerings include digital strategy consulting, user experience and interface design, cloud-native application development, data engineering and full-cycle product lifecycle management.
Leveraging a proprietary agile framework, CI&T helps organizations accelerate time-to-market and improve operational efficiency through continuous delivery and DevOps automation.
Recommended Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider CI&T, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CI&T wasn't on the list.
While CI&T currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries.
"Physical AI" is coming to the United States, and there are four ways that investors can gain exposure to this new robotics revolution. Plus, learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.